Lacutamab (IPH 4102) is a potent and selective humanized anti-KIR3DL2 antibody.Lacutamab has potential anticancer activity for the study of leukemia and lymphoma.
CAS Number:
[2187368-16-5]
Target:
IPH 41 , IPH 4102
* VAT and and shipping costs not included. Errors and price changes excepted